HeartWare slides on stroke results from heart pump studies

Higher-than-expected stroke rates reported in a pair of studies of HeartWare's implantable heart pump this week spook investors, pushing HTWR share prices down more than 8%.

HeartWare International Inc., Thoratec Corp.

News Well, Clinical Trials, Cardiac Assist Devices

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1GP2VTt